These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 14707046)

  • 1. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
    Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
    J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts.
    Solomon MF; Kuziel WA; Mann DA; Simeonovic CJ
    Xenotransplantation; 2003 Mar; 10(2):164-77. PubMed ID: 12588649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
    Solomon MF; Kuziel WA; Simeonovic CJ
    Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection.
    Abdi R; Smith RN; Makhlouf L; Najafian N; Luster AD; Auchincloss H; Sayegh MH
    Diabetes; 2002 Aug; 51(8):2489-95. PubMed ID: 12145162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.
    Schröppel B; Zhang N; Chen P; Zang W; Chen D; Hudkins KL; Kuziel WA; Sung R; Bromberg JS; Murphy B
    J Am Soc Nephrol; 2004 Jul; 15(7):1853-61. PubMed ID: 15213273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived IP-10 initiates development of acute allograft rejection.
    Hancock WW; Gao W; Csizmadia V; Faia KL; Shemmeri N; Luster AD
    J Exp Med; 2001 Apr; 193(8):975-80. PubMed ID: 11304558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines in islet allograft rejection.
    Abdi R; Means TK; Luster AD
    Diabetes Metab Res Rev; 2003; 19(3):186-90. PubMed ID: 12789651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
    Hancock WW; Lu B; Gao W; Csizmadia V; Faia K; King JA; Smiley ST; Ling M; Gerard NP; Gerard C
    J Exp Med; 2000 Nov; 192(10):1515-20. PubMed ID: 11085753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
    Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
    Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity.
    McKee CM; Defina R; He H; Haley KJ; Stone JR; Perkins DL
    J Immunol; 2002 Jan; 168(1):483-9. PubMed ID: 11751996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.
    Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB
    Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
    Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
    J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection.
    Chandra AP; Ouyang L; Yi S; Wong JK; Ha H; Walters SN; Patel AT; Stokes R; Jardine M; Hawthorne WJ; O'Connell PJ
    Xenotransplantation; 2007 Jan; 14(1):48-59. PubMed ID: 17214704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
    Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
    J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
    Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
    Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
    Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
    J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.